Keywords: Flavonoid; Gastrointestinal tract; Intestinal permeability; Incretins; Endotoxemia; Microbiota; CRC; colorectal cancer; DPP-IV; dipeptidyl peptidase IV; EC; (â)-epicatechin; EGCG; (â)-epigallocatechin gallate; GLP-1; glucagon-like peptide-1; GLP-2; gl
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Short bowel syndrome; Massive bowel eresection; Intestinal adaptation; Parenteral nutrition-associated liver disease; Parenteral nutrition; Gastrointestinal hormone; Ghrelin; GLP-2; IGF-1; Pediatric surgery;
Keywords: Short bowel syndrome; Intestinal adaptation; Parenteral nutrition; Trophic factors; GLP-2; Rehabilitative surgery;
Keywords: ACC; Acetyl-CoA carboxylase; ACSL; Long-chain acyl-CoA synthetase; AMPK; AMP-activated protein kinase; Apo; Apolipoprotein; ATGL; Adipose triglyceride lipase; CD36; Cluster of differentiation 36; CGI-58; Comparative gene identification-58; CIDE; Cell deat
Keywords: A5; A5 catecholamine cell group; Amb; nucleus ambiguous; AP; area postrema; CNS; central nervous system; CVLM; caudal ventrolateral medulla; DAB; diaminobenzidine; DMH; dorsomedial hypothalamic nucleus; Fos-IR; Fos immunoreactivity; GAD; glutamic acid dec
Keywords: Glucagon; Glucagon-like peptides; GLP-1; GLP-2; Glucagon receptors; Evolution; Genomics; Fish;
Keywords: Short bowel syndrome; GLP-2; Liver failure;
Keywords: β-Glucans; Inflammation; PYY; GLP-1; GLP-2; Ghrelin; Glucose; Insulin; Cancer;
Keywords: Gut microbiota; Microbiome; Shift work; Sleep disruption; Circadian disruption; GLP-2; glucagon-like peptide-2; IFN-γ; interferon gamma; T2D; type 2 diabetes; TNFα; tumor necrosis factor alpha;
Keywords: ACTH; adrenocorticotropic hormone; BBB; blood-brain barrier; BLA; basolateral amygdala; CNS; central nervous system; CPPs; cell penetrating peptides; DMH; dorsomedial hypothalamic nucleus; DMSO; dimethylsulfoxide; DPP-IV; dipeptidyl peptidase IV; FAM; car
Keywords: GLP-2; GLP-1; Amino acid absorption; Rapamycin; Gut peptides; mTORC1; mechanistic target of rapamycin complex 1; 4E-BP1; eukaryotic translation initiation factor 4E (eIF4e)-binding protein 1; GLP-1; Glucagon-like peptide-1; AA; amino acid; LC-MS/MS; liqui
Keywords: ACC; anterior cingulate cortex; ATP; adenosine triphosphate; CB; cannabinoid receptor; CD; Chron's disease; CGRP; calcitonin-gene related peptide; CNS; central nervous system; CRF; corticotropin releasing factor; ECC; enterochromaffin cell; ENS; enteric n
Keywords: AA; amino acid; ADFI; average daily feed intake; ADG; average daily gain; Ala; alanine; ANFs; anti-nutritive factors; Asn; asparagine; Asp; aspartate; CaSR; calcium sensing receptor; CCK; cholecystokinin; CD36; cluster of differentiation 36; dlM; dl-methi
Keywords: AMEn; apparent metabolizable energy (nitrogen corrected); gut; gastrointestinal tract; CCK; cholecystokinin; PYY; Peptide YY; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-like peptide-2; Broilers; Laying hens; Energy homeostasis; Genotype; Feed form; E
Keywords: ACa; albumin-adjusted calcium; ANOVA; analysis of variance; AUC; area under the curve; BASE; baseline; BMD; bone mineral density; BMI; body mass index; BT ratio; bone turnover ratio; BTMs; bone turnover markers; CON; controlled; β-CTX; β-carboxyl-termin
Keywords: GLP-2; Pig; Weaning; Birth; Enteritis; Enteroendocrine;
Keywords: GLP-1; glucagon-like peptide 1; GLP-2; glucagon-like peptide 2; GLP-2R; GLP-2 receptor; HFD; high fat diet; PC; prohormone convertase; POMC; proopiomelanocortin; GLP-2; L-type enteroendocrine cells; Food intake; Obesity; Insulin resistance;
Keywords: GLP-1; GLP-2; Radiation-enteritis; Myeloperoxidase; Glutathione
Keywords: Intestinotrophic; GLP-2; GLP-2R; RT-PCR; Enteric neurons;
Keywords: ALT; alanine aminotransferase; AMPK; AMP-activated protein kinase; AST; aspartate aminotransferase; CDAA diet; choline-deficient/l-amino acid-defined diet; GLP-2; glucagon-like peptide-2; HFD; high fat diet; IL-1; interleukin 1; IL-6; interleukin 6; Fiaf;
Keywords: EN; Enteral nutrition; GLP-2; Glucagon-like peptide 2; IF; Intestinal failure; PN; Parenteral nutrition; SBS; Short bowel syndrome;
Keywords: Intestine; Lipoprotein; Chylomicron; GLP-1; GLP-2; Resveratrol; Apo; apolipoprotein; CVD; cardiovascular diseases; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GIP; gastric inhibitory polypeptide; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-l
Keywords: Enterocyte; Plasma Lipid; Fatty Acid; Human Trial; ANOVA; analysis of variance; apoB; apolipoprotein B; AUC0-3; area under the concentration curve in the first 3 hours after treatment; BMD; bone mineral density; DPP-IV; dipeptidyl peptidase IV; FCR; fra
Keywords: GLP-2; glucagon-like peptide-2; p-CTX; plasma-carboxy-terminal telopeptide of type 1 collagen; AUC; area under the curve; pmol; picomole; nmol; nanomole; mg; milligram; DPP-4; dipeptidylpeptidase-4; cm; centimeter; kg/m2; kilogram/square meter; EDTA; etyl
Keywords: CNS; central nervous system; CVLM; caudal ventrolateral medulla; DMH; dorsomedial hypothalamus; Fos-IR; c-Fos immunoreativity; GLP-2; glucagon-like peptide-2; i.c.v.; intracerebroventricular; IML; intermediolateral nucleus; i.v.; intravenous; LC; locus co
Keywords: GLP-1; GLP-2; Endocannabinoids; Metabolic endotoxaemia; Gut permeability; Prebiotics; Diabetes;
Keywords: GLP-2, glucagon-like peptide-2; NEC, necrotizing enterocolitis; TNF-α, tumor necrosis factor; IL-6, interleukine-6NEC; GLP-2; Inflammation; Cytokines; Neonate
Oral Bifidobacterium longum expressing GLP-2 improves nutrient assimilation and nutritional homeostasis in mice
Keywords: Bifidobacterium longum; GLP-2; Chylomicron; Triglyceride;
GLP-2 receptor signaling controls circulating bile acid levels but not glucose homeostasis in Gcgrâ/â mice and is dispensable for the metabolic benefits ensuing after vertical sleeve gastrectomy
Keywords: Glucagon; GLP-1; GLP-2; Bile acids; Bariatric surgery; Glucose; Diabetes; Obesity;
Prise en charge médico-chirurgicale du syndrome de grêle court
Keywords: Syndrome de grêle court; Adaptation intestinale; Nutrition parentérale; Facteurs trophiques; Chirurgie de réhabilitation; Short bowel syndrome; Intestinal adaptation; Parenteral nutrition; Trophic factors; GLP-2; Rehabilitative surgery;
Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis
Keywords: AMC; aminomethylcoumarin; CD; Crohn's disease; DIP; diprotin; DMSO; dimethyl sulfoxide; DPP; IV dipeptidyl peptidase IV; DSS; dextran sulfate sodium; EM-2; endomorphin-2; GAPDH; glycerylaldehyde-3-phosphate dehydrogenase; GI; gastrointestinal; GLP-1; gl
Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice
Keywords: GLP-1; GLP-2; Co-agonist; Diabetes; Obesity; Short bowel syndrome; Intestinal growth; Glucose homeostasis;
Is OM-3 synergistic with GLP-2 in intestinal failure?
Keywords: GLP-2; OM-3; Glucagon-like Peptide-2; Omega-3; Fatty acid; MSBR; Short gut syndrome; Intestinal failure; Bowel adaptation; Intestinal adaptation;
Differential expression of glucagon-like peptide-2 (GLP-2) is involved in pancreatic islet cell adaptations to stress and beta-cell survival
Keywords: Beta-cell; Alpha-cell; Islets; Proglucagon; GLP-2; GLP-2 receptor; Insulin secretion; Diabetes; Proliferation; Apoptosis;
Glucagon-like petide-2 acts on colon cancer myofibroblasts to stimulate proliferation, migration and invasion of both myofibroblasts and cancer cells via the IGF pathway
Keywords: ATMs; adjacent tissue myofibroblasts; CAMs; cancer associated myofibroblasts; GLP-2; glucagon-like peptide 2; IGF; insulin-like growth factor; IGFBP; insulin-like growth factor binding protein; MMP; matrix metalloproteinase; GLP-2; IGF; IGFBP; Myofibrobla
Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway
Keywords: Bile acids; Gallbladder; Enteroendocrine; Glucagon-like peptide; TGR5; GLP-1; GLP-2;
Research articleDetailed characterisation of STC-1 cells and the pGIP/Neo sub-clone suggests the incretin hormones are translationally regulated
Keywords: CCK; cholecystokinin; HCA; high content analysis; GIP; glucose-dependent insulinotropic peptide; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-like peptide- 2; PYY; peptide YY; PC3; prohormone convertase 3; T2DM; type 2 diabetes mellitus; E2D2; ubiquiti
Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition
Keywords: Total Parenteral Nutrition; EGF; GLP-2; EGFR; PI3K; Mucosal Atrophy; bp; base pair; EGF; epidermal growth factor; EGFR; epidermal growth factor receptor; GLP-2; glucagon-like peptide 2; GLP2R; glucagon-like peptide 2 receptor; GLP-2 (3-33); glucagon-like
The Na+-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer
Keywords: AMG; α-methyl-D-glucopyranoside; BBB; blood brain barrier; BBM; brush-border membrane; BLM; basolateral membrane; CREB; cAMP response element binding protein; DNJ; 1-deoxynojirimycin; EKA; euglycemic ketoacidosis; GGM; glucose-galactose malabsorption; GI
LARETH-25 and β-CD improve central transitivity and central pharmacological effect of the GLP-2 peptide
Keywords: β-CD; β-cyclodextrin; LAURETH-25; Polyoxyethylene (25) lauryl ether; GLP-2; Glucagon-like peptide-2; DPP-4; Dipeptidyl Peptidase-4; BBB; Blood-Brain Barrier; Amy; Amygdala; CNS; Central nervous system; CMC; Critical Micelle Concentration; Glucagon-lik
GLP-2: What do we know? What are we going to discover?
Keywords: GLP-2; GLP-2 receptor; The gastrointestinal tract; The enteric nervous system;
A dose-equivalent comparison of the effects of continuous subcutaneous glucagon-like peptide 2 (GLP-2) infusions versus meal related GLP-2 injections in the treatment of short bowel syndrome (SBS) patients
Keywords: Short bowel syndrome; GLP-2; Intestinal insufficiency; Intestinal failure; Absorption; Treatment modality;
Ghrelin and glucagon-like peptide-2 increase immediately following massive small bowel resection
Keywords: GLP-2; glucagon-like peptide-2; 80% SBR; 80% small bowel resection; Acyl ghrelin; Des-acyl ghrelin; GLP-2; Adaptation; Massive small bowel resection; Short bowel syndrome;
Distribution of K and L cells in the feline intestinal tract
Keywords: Diabetes mellitus; Incretin; Obesity; GLP-1; GLP-2; GIP
Neuronal Fos-like immunoreactivity associated with dexamethasone-induced hypertension in rats and effects of glucagon-like peptide-2
Keywords: Dexamethasone; c-Fos protein; Blood pressure; Hypothalamus; GLP-2
Glucagon-like peptide 2 increases efficacy of distraction enterogenesis
Keywords: GLP-2; Distraction-induced growth; Enterogenesis; Vascularity; Microfil; Polyethylene glycol (PEG); Cell proliferation
Influence of acylation on the adsorption of GLP-2 to hydrophobic surfaces
Keywords: Acylation; Protein adsorption; GLP-2; ITC; Reflectometry; TIRF
Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure
Keywords: Short Bowel; Intestinal Failure; GLP-2; ECL; electrochemiluminescent; ECP; Escherichia coli protein; GH; growth hormone; GLP-2; glucagon-like peptide-2; IV; intravenous; PN; parenteral nutrition; RCT; randomized controlled trial; SAE; serious adverse even
GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier
Keywords: CD; Crohn's disease; DSS; dextran sodium sulphate; EDTA; ethylenediaminetetraacetic acid; GLPâ2; glucagonâlike peptide 2; IFNγ; interferon gamma; IL; interleukin; IGF; insulin growth factor; MAGUK; membrane associated guanylate kinase; MLCK; myosin l
Inulin-enriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers
Keywords: AUC; area under the curve; ELISA; enzyme-linked immunosorbent assay; GI; gastrointestinal; GLP-2; glucagon-like peptide 2; IP; intestinal permeability; La; lactulose; NAFLD; nonalcoholic fatty liver disease; Ma; mannitol; Glucagon-like peptide 2; Intestin